课题基金 / 基金详情

Integrative Investigation of Mitochondrial Dysfunction

Integrative Investigation of Mitochondrial Dysfunction
线粒体功能障碍的综合研究
批准号:
8296616
负责人:
FADI GABRIEL AKAR
金额:
$29.66万
依托单位国家:
美国
项目类别:
财政年份:
2011
资助国家:
美国
项目状态:
已结题
起止时间:
2011-07-15 至 2013-06-30

项目摘要

项目成果

FADI GABRIEL AKAR的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): The mitochondrial membrane potential (DYm) is a key regulator of mitochondrial function that drives the production of ATP and reactive oxygen species (ROS). Dynamic oscillations of DYm in isolated cardiac myocytes can result in electrophysiological oscillations that significantly impact myocyte function and lead to inexcitability at the cellular level. However, technical challenges in measuring spatio-temporal gradients in metabolic function within the intact heart have precluded a direct investigation of the functional consequences of unstable mitochondrial properties in mediating global oxidative stress and associated mechano-electrical dysfunction. Since the original submission of this proposal, we have developed a semi-quantitative imaging technique for measuring the spatio-temporal dynamics of DYm with subcellular resolution at the organ level. In this proposal, we extend our measurements to perform ROS imaging in order to investigate if ROS-induced ROS-release is a mechanism of DYm instability within the intact normal and hypertrophied heart. Previous work identified the mitochondrial benzodiazepine receptor (mBZR) as a potentially attractive candidate for preventing arrhythmias. However, pharmacological interventions that target mBzR significantly impact contractile and calcium handling properties by directly suppressing the L-type calcium current. This may limit the clinical utility of these agents and raises important questions regarding the direct relevance of DYm stability per se in altering mechano-electrical properties. We will directly address this important issue by using a gene transfer approach that targets mBZR expression. This will uncover the role of IMAC through mBZR overexpression in altering mitochondrial, mechanical, and electrical properties. From a practical perspective, these studies will help us determine if modulation of mBZR expression is a viable strategy for altering mechano-electrical properties. If so, future gene silencing to mimic IMAC blockade may be warranted.
期刊论文(4)
专著(0)
科研奖励(0)
会议论文
DOI: 10.1016/j.jacc.2015.06.1329
发表时间: 2015-09-08
期刊: Journal of the American College of Cardiology
影响因子: 24
作者: [Xie C, Hu J, Motloch LJ, Karam BS, Akar FG]
通讯作者: Akar FG
Regression of cardiac hypertrophy by cyclic guanosine monophosphate-dependent protein kinase signaling are myocytes active sources or mere beneficiaries?
通过环鸟苷单磷酸依赖性蛋白激酶信号传导来消退心脏肥大是心肌细胞的活性来源还是仅仅是受益者?
DOI: 10.1016/j.jacc.2010.09.005
发表时间: 2010
期刊: Journal of the American College of Cardiology
影响因子: 24
作者: [Hajjar,RogerJ, Akar,FadiG]
通讯作者: Akar,FadiG
DOI: 10.1161/circresaha.112.274308
发表时间: 2013-01-18
期刊: Circulation research
影响因子: 20.1
作者: [Nederlof R, Xie C, Eerbeek O, Koeman A, Milstein DM, Hollmann MW, Mik EG, Warley A, Southworth R, Akar FG, Zuurbier CJ]
通讯作者: Zuurbier CJ
DOI: 10.1161/jaha.112.001412
发表时间: 2012-04
期刊: Journal of the American Heart Association
影响因子: 5.4
作者: [Karam CS, Akar FG]
通讯作者: Akar FG
Desmoplakinopathies: Integrated Pathophysiology and Therapeutics
  • 批准号:
    10659458
  • 项目类别:
  • 资助金额:
    $67.36万
  • 财政年份:
    2023
  • 负责人:
    FADI GABRIEL AKAR
  • 依托单位:
Optimizing AF ablation by a novel optogenetics and computational approach
  • 批准号:
    10676183
  • 项目类别:
  • 资助金额:
    $20.94万
  • 财政年份:
    2022
  • 负责人:
    FADI GABRIEL AKAR
  • 依托单位:
Optimizing AF ablation by a novel optogenetics and computational approach
  • 批准号:
    10508937
  • 项目类别:
  • 资助金额:
    $25.13万
  • 财政年份:
    2022
  • 负责人:
    FADI GABRIEL AKAR
  • 依托单位:
Metabolic signaling in atrial fibrillation and remodeling
  • 批准号:
    10393659
  • 项目类别:
  • 资助金额:
    $55.21万
  • 财政年份:
    2021
  • 负责人:
    FADI GABRIEL AKAR
  • 依托单位:
海外基金